Effects of Coffee Roasting on Blood Sugar Levels in Healthy Humans

Sponsor
North Carolina State University (Other)
Overall Status
Completed
CT.gov ID
NCT05119153
Collaborator
(none)
19
1
4
23.9
0.8

Study Details

Study Description

Brief Summary

The present study determined the effects light, medium, and dark roasted, brewed coffees on blood glucose responses in normal (n = 19) subjects.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Placebo Comparator
  • Dietary Supplement: Light Roasted Coffee
  • Dietary Supplement: Medium Roasted Coffee
  • Dietary Supplement: Dark Roasted Coffee
N/A

Detailed Description

This is a single-blinded, randomized partial block design conducted over 6 weeks in two parts.

In part 1 (3 weeks), participants were randomly assigned to consume four beverages: a placebo containing water and caramel color, light, medium, or dark roast coffee before, during, or after consumption of a beverage containing 50 g of glucose.

In part 2 (3 weeks), participants were randomly assigned to consume four beverages: a placebo containing water and caramel color, light, medium, or dark roast coffee before, during, or after consumption of a standardized breakfast (corn flakes cereal + skim milk) containing 50 g of glucose.

In each part, fasting and postprandial glucose profiles were determined.

Study Design

Study Type:
Interventional
Actual Enrollment :
19 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Randomized, single-blinded, partial block, crossover designRandomized, single-blinded, partial block, crossover design
Masking:
Single (Participant)
Masking Description:
Subjects provided placebo and coffee beverages in a color coded bottles
Primary Purpose:
Basic Science
Official Title:
Effects of Coffee Roasting on Blood Sugar Levels in Healthy Humans
Actual Study Start Date :
Nov 5, 2019
Actual Primary Completion Date :
Dec 20, 2020
Actual Study Completion Date :
Oct 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Placebo Comparator

Placebo composed of water and caramel color.

Dietary Supplement: Placebo Comparator
Placebo designed to mimic coffee color.

Experimental: Light Roasted Coffee

12 oz light roast coffee beverage prepared at 55 g ground coffee/L water

Dietary Supplement: Light Roasted Coffee
12 oz light roast coffee

Experimental: Medium Roasted Coffee

12 oz medium roast coffee beverage prepared at 55 g ground coffee/L water

Dietary Supplement: Medium Roasted Coffee
12 oz medium roast coffee

Experimental: Dark Roasted Coffee

12 oz dark roast coffee beverage prepared at 55 g ground coffee/L water

Dietary Supplement: Dark Roasted Coffee
12 oz dark roast coffee

Outcome Measures

Primary Outcome Measures

  1. Changes in Blood Glucose [6 weeks]

    Each week, fasted baseline and postprandial measurements taken out to 240 minutes

Secondary Outcome Measures

  1. Changes in Glucose Area Under the Curve [6 weeks]

    Used glucose changes over 240 minutes to construct area under the curve

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

• Age 18-64 years old with BMI less than 29 and fasting blood glucose less than 125 mg/dl.

Exclusion Criteria:
  • Age 18-64 years old with BMI less than 29 and fasting blood glucose less than 125 mg/dl.

  • Weight less than 110 pounds (55 kg)

  • Pre-existing health conditions, such as:

  • High cholesterol

  • Hypertension

  • Cardiovascular disease

  • Gastrointestinal motility disorders

  • Hypo- or hyperthyroidism

  • Anemia

  • Renal disease

  • Liver disease, including hepatitis B or C, cholestasis, cirrhotic liver disease, or non-alcoholic fatty liver disease

  • Chronic or acute pancreatitis

  • Diabetes type 1 or 2

  • Insulin resistance

  • Polycystic ovary syndrome

  • Food allergies or intolerances to coffee/caffeine/dairy/corn-based cereals.

  • Currently taking prescription medication

  • Current smoker

  • Consumes more than 3 alcoholic beverages per day

  • Pregnant or breastfeeding

  • Not willing to take their own blood samples with finger sticks

Contacts and Locations

Locations

Site City State Country Postal Code
1 Schaub Hall, Campus Box 7624 Raleigh North Carolina United States 27695

Sponsors and Collaborators

  • North Carolina State University

Investigators

  • Principal Investigator: Gabriel K Harris, PhD, North Carolina State University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gabriel Keith Harris, Associate Professor of Food Science, North Carolina State University
ClinicalTrials.gov Identifier:
NCT05119153
Other Study ID Numbers:
  • 16857
First Posted:
Nov 12, 2021
Last Update Posted:
Nov 12, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Gabriel Keith Harris, Associate Professor of Food Science, North Carolina State University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 12, 2021